Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1

Feb. 3, 2022

New prolyl endopeptidase inhibitors identified at Accure Therapeutics

Feb. 3, 2022

Sarepta and GenEdit report progress under collaboration for neuromuscular diseases

Feb. 2, 2022

CCR4 mediates postoperative pain through skin dendritic cells

Feb. 2, 2022

ATH-434 demonstrates efficacy in preclinical multiple system atrophy

Jan. 31, 2022

New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding

Jan. 31, 2022

Dual Kv7 channel/TPSO receptor activator GRT-X shows promise in a refractory seizure model

Jan. 31, 2022

Gilgamesh Pharmaceuticals identifies new 5-HT2A receptor agonists

Jan. 28, 2022

Structure-based psychedelic analogue discovery reported

Jan. 28, 2022

Chinese investigators describe AGTR2 antagonists

Jan. 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...